1. Baur B, Andreolli E, Al-Momani E, Malik N, Machulla HJ, Reske SN, Solbach C. Synthesis and labelling of Df-DUPA-Pep with gallium-68 and zirconium-89 as new PSMA ligands. J Radioanal Nucl Chem 2014; 299:1715-1721.
  2. Bubolz AM, Weissinger SE, Stenzinger A, Arndt A, Steinestel K, Bruderlein S, Cario H, Lubatschofski A, Welke C, Anagnostopoulos I, Barth TF, Beer AJ, Moller P, Gottstein M, Viardot A, Lennerz JK. Potential clinical implications of BRAF mutations in histiocytic proliferations. Oncotarget 2014; 5:4060-4070.
  3. Jilg CA, Schultze-Seemann W, Drendel V, Vach W, Wieser G, Krauss T, Jandausch A, Holz S, Henne K, Reske SN, Grosu AL, Weber WA, Rischke HC. Detection of Lymph Node Metastasis in Patients with Nodal Prostate Cancer Relapse Using F-18/C-11-Choline Positron Emission Tomography/Computerized Tomography. J Urol 2014; 192:103-110.
  4. Kletting P, Schimmel S, Kestler HA, Hanscheid H, Luster M, Fernandez M, Broer JH, Nosske D, Lassmann M, Glatting G. Erratum: Molecular radiotherapy: The NUKFIT software for calculating the time- integrated activity coefficient (vol 40, pg 102504, 2013). Med Phys 2014; 41.
  5. Miller L, Winter G, Baur B, Witulla B, Solbach C, Reske S, Linden M. Synthesis, characterization, and biodistribution of multiple Zr-89-labeled pore-expanded mesoporous silica nanoparticles for PET. Nanoscale 2014; 6:4928-4935.
  6. Philipp-Abbrederis K, Herrmann K, Schottelius M, Eiber M, Knop S, Rudelius M, Beer A, Gerngross C, Pietschmann E, Gotze K, Kropf S, Peschel C, Einsele H, Buck A, Schwaiger M, Wester HJ, Keller U. Disclosing the CXCR4 expression status in multiple myeloma by in vivo molecular imaging. Oncology Research and Treatment 2014; 37:193-193.